Active — Not RecruitingNot Applicable

Cervical Lordosis: Imaging Position and Measurement

Turkey (Türkiye)58 participantsStarted 2025-01-01

Plain-language summary

This retrospective cross-sectional study aims to compare cervical lordosis measurements obtained from standing lateral radiographs and supine magnetic resonance imaging (MRI) in individuals without structural cervical pathology. The study also evaluates the independent contribution of T1 slope to cervical alignment and investigates whether imaging modality significantly alters measured lordosis values.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 to 65 years * Availability of standing lateral cervical radiograph or supine cervical MRI performed during the registry period * No structural cervical pathology affecting sagittal alignment * Images of adequate quality for radiographic measurement * Neutral standing radiograph position for Standing Radiograph Group * Standard supine acquisition for Supine MRI Group Exclusion Criteria: * Prior cervical spine surgery * Cervical fracture, dislocation, or whiplash history * Primary or metastatic cervical malignancy * Congenital vertebral anomaly including Klippel-Feil syndrome, os odontoideum, hemivertebra, block vertebra, or atlantoaxial instability * Spinal deformity or postural disorder likely to affect cervical alignment, including scoliosis, hyperkyphosis, or Scheuermann disease * Advanced degenerative cervical disease, including severe spondylosis, cervical spinal stenosis, OPLL, or DISH * Inflammatory or autoimmune rheumatologic disease affecting the spine * Neuromuscular or neurologic disorders affecting posture or alignment * Inadequate image quality, major artifact, or improper positioning

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Difference in Cobb C2-C7 angle between standing radiographs and supine MRI

Timeframe: Baseline retrospective image assessment

Difference in Cobb C1-C7 angle between standing radiographs and supine MRI

Timeframe: Baseline retrospective image assessment

Trial details

NCT IDNCT07541586

SponsorMedipol University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-01

View on ClinicalTrials.gov More Cervical Lordosis trials